The CDC advisory committee could determine the Johnson and Johnson COVID-19 vaccine is safe to use again after being on hold due to reports of rare blood clots developing. Dr. Jonathan Kantor, Epidemiologist at the Penn Center for Epidemiology joins us to discuss this possible decision.
